Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer
The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.
JINAN,China,May 24,2024-- Recently,Inspur signed strategic cooperation agreements with Malaysia\'s large data center operator and Singapore\'s A3 Capital to jointly promote the development of the data
Bringing the First Global Cross-Disciplinary Immersive Entertainment Product BEIJING,May 24,2024-- In a strategic move to enhance its international market presence,Innomix is developing and producing
TAIPEI,May 24,2024-- DEKRA,the automotive technology service provider recognized by EU government agencies,announced that it has successfully audited VicOne,a subsidiary of the cybersecurity giant Tr
HONG KONG,May 24,2024-- Digital transformation specialistGienTech and China Computer Federation (CCF) Digital Finance successfully co-hosted the "2024 GienTech Digital Transformation Conference&
